John T T Stutts

Dr. John T T Stutts


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
Carlett RamirezCarlett Ramirez
Carlett Ramirez
JOJeffery S. Oliver
Jeffery S. Oliver
JSJane Schlezinger
Jane Schlezinger
JSJohn T T Stutts
John T T Stutts
Background: The purpose of this research was to assess the growth, tolerance, and compliance outcomes associated with the consumption of a hydrolyzed rice infant formula (HRF) enriched with 2′-Fucosyllactose (2′-FL) a Human Milk Oligosaccharide (HMO), and nucleotides in an intended population of infants. Methods: This was a non-randomized single-group, multicenter study. The study formula was a hypoallergenic HRF with 2′-FL, Docosahexaenoic acid (DHA), Arachidonic acid (ARA), and nucleotides. Infants 0–90 days of age who were formula fed and experiencing persistent feeding intolerance symptoms, symptoms of suspected food protein (milk and/or soy) allergy, or other conditions where an extensively hydrolyzed infant formula was deemed an appropriate feeding option were recruited by pediatricians from their local populations. The primary outcome was maintenance of weight-for-age z-score. Weight, length, head circumference, formula intake, tolerance measures, clinical symptoms and questionnaires were collected. Thirty-three infants were enrolled, and 27 completed the study, on study product. Results: Weight-for-age z-scores of infants showed a statistically significant improvement from Visit 1 to Visit 4 (p = 0.0331). There was an adequate daily volume intake of 762 ± 28 mL/day, average daily number of stools of 2.1 ± 0.3, and mean rank stool consistency of 2.38 ± 0.18. After 28 days of switching to a HRF, 86.8 ± 5.9% of the symptoms resolved or got better by Visit 4 as reported by parents. Conclusions: HRF with 2′-FL HMO was safe, well tolerated, and supported weight gain in infants with suspected cow’s milk allergy or persistent feeding intolerance.

26 November 2024 in Children
Verified
Journal Article
Open access
PDF file
ASAmy Richele Sharn
Amy Richele Sharn
WPWendy Phillips
Wendy Phillips
JSJohn T T Stutts
John T T Stutts
MKMary M Kaminski
Mary M Kaminski
ASAmy Shepps
Amy Shepps
Mary Beth ArensbergMary Beth Arensberg
Mary Beth Arensberg
Nutrition is fundamental to a child’s growth and development. However, nutritional health is often compromised by acute and chronic conditions and treatments that can commonly result in malnutrition. Malnutrition encompasses undernutrition and overnutrition and may be exacerbated by food insecurity. Recent health policy efforts in the United States (US) include those focused on quality measurement and social determinants of health (SDOH) to reduce risks for malnutrition and food insecurity. Nutrition-focused quality improvement programs (QIPs) have emerged as a successful model for benchmarking current nutrition care in adult patients and creating pathways for establishing best practices for timely malnutrition screening, intervention, and appropriate follow-up and care coordination. However, less is known about opportunities for nutrition-focused QIPs in hospital pediatric malnutrition care. This Perspective helps fill the gap by discussing the problem of pediatric malnutrition and current US quality frameworks and child nutrition programs related to malnutrition and food insecurity. In addition, this Perspective summarizes how nutrition-focused QIPs can impact malnutrition, including how QIPs can link hospital care with patient discharge planning and outpatient interventions. Finally, the Perspective outlines specific opportunities for the implementation of pediatric nutrition-focused QIPs to reduce office visits and/or inpatient readmissions through appropriate nutrition screening, assessment, and interventions.

3 December 2025 in Obesity Pillars
Verified
Journal Article
Open access
JSJohn T T Stutts
John T T Stutts
YCYong S. Choe
Yong S. Choe
ABAshley Bronston
Ashley Bronston
Adolescence is a critical period of growth with elevated nutritional demands, yet many U.S. adolescents fail to meet recommended dietary intakes. This study analyzed data from three NHANES cycles (2013–2018) to assess obesity trends among adolescents aged 12–18, compare dietary intake by BMI, and evaluate nutritional biomarkers. This retrospective observational study analyzed data from three NHANES cycles to estimate obesity prevalence among U.S. adolescents aged 12–18 years. Dietary intake and blood concentrations of micro- and macronutrients were compared between adolescents with and without obesity. Obesity was defined as BMI ≥95th percentile per CDC growth charts. Nutrient intake was assessed against Estimated Average Requirement (EAR) and Adequate Intake (AI) benchmarks, and biomarker levels were evaluated using established clinical thresholds. All statistical analyses were conducted using SAS version 9.4 and SAS Enterprise Guide version 8.3. Obesity prevalence increased slightly from 20.3% to 21.3% across cycles. Among all dietary intake variables analyzed, only one demonstrated a statistically significant difference between those with obesity and those without. The adolescents with obesity were significantly more likely to have protein intakes below the EAR (50.3% vs. 22.9%, P < 0.001). Over half of all adolescents failed to meet recommended intake levels for several nutrients, regardless of their BMI categories. The blood biomarker analysis revealed significantly lower levels of vitamin D, vitamin C, serum iron, albumin, and MCV in those with obesity, alongside higher levels of total protein, globulin, and hs-CRP (P ≤ 0.05). The prevalence of low vitamin D, low hemoglobin, low MCV, and iron deficiency anemia was also significantly higher in the group with obesity. This study reveals that despite similar caloric intakes, adolescents with obesity exhibited higher rates of nutrient deficiencies and markers of inflammation. This work underscores the importance of recognizing nutrition gaps in adolescent care.

8 October 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
RMRobert D Murray
Robert D Murray
MTMatthew D Teegarden
Matthew D Teegarden
AGAndie Lee Gonzalez
Andie Lee Gonzalez
Mary Beth ArensbergMary Beth Arensberg
Mary Beth Arensberg
JSJohn T T Stutts
John T T Stutts
Specialized nutrition products are often used as a component of nutrition care across a spectrum of acute and chronic pediatric medical conditions. These products differ from conventional foods due to their clinical purpose, composition, and context of use, yet these distinguishing characteristics are rarely discussed collectively. The objective of this narrative review is to provide an interdisciplinary overview of specialized pediatric nutrition products, including their clinical applications, formulation considerations, regulatory environment, and future opportunities for innovation and evidence generation. These products are specially formulated and processed to provide nutrition support for vulnerable children during critical periods of growth and development. At the same time, they are subject to specialized and complex regulations. Globally, there is increased interest in the role of food formulation and processing in childhood nutrition. As policy landscapes evolve, attention should be given to specialized pediatric nutrition products to ensure continued availability and support for future research and innovations that benefit pediatric growth, development, and health outcomes.